Daniel Van Den Bergh

Director at Validic


Daniel Van Den Bergh is a Director at Validic. Daniel has also served as a Board Observer for NOCD, Ordr Inc., and Talix, an Edifecs Company. In addition, they have been a Director for Kaiser Permanente Ventures and Protenus.

Mr. Van Den Bergh has over 15 years of experience in the healthcare industry. Daniel started their career as a consultant for Arthur Andersen and then worked as a strategy and business development executive for McKesson. Daniel then joined Kaiser Permanente Ventures, where they were a founding member of the team and helped lead KPV's healthcare information technology investments.

In 2017, Mr. Van Den Bergh joined Validic as a Board Director. Validic is a leading digital health platform that connects patient-generated data from more than 5,000 devices and apps to the healthcare ecosystem. In their role at Validic, Mr. Van Den Bergh is responsible for leading KPV's investment in the company's Series B financing.

Daniel Van Den Bergh holds an MBA from the Wharton School and a BS from Cornell University in biological engineering and applied economics.


  • Director

    Current role

View in org chart